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Safety and Quality in Healthcare, looking at Clinical 
Indicators to further understand the performance of 
healthcare organisations.
As clinical care changes, the challenges for the Australian 
Council on Healthcare Standards are to ensure the 
Clinical Indicators continue to reflect current practice, 
to retain clinician support, and also to ensure that the 
existence of its extensive and long-standing national 
clinical database is more widely known and utilised.
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Abstract
The Clinical Indicator Program, which was introduced 
into the Australian Council on Healthcare Standards’ 
accreditation program two decades ago, has grown 
from one set addressed by 115 healthcare organisations 
to 22 sets with data received from over 800 healthcare 
organisations, resulting in a national database which 
is unique in its clinical diversity, reflecting every major 
medical discipline involved in hospital practice. The 
process for Clinical Indicator selection and review 
remains with the providers of the care, but the selection 
criteria are better defined and the evidence base 
strengthened. Early responses to their introduction were 
encouraging as improvements in patient management 
and outcomes were sought and achieved following 
review of comparative data, and some examples of 
these are provided. Clinical Indicator revision remains 
an important and major task and the original Hospital-
Wide set of Clinical Indicators is now in its 12th version. 
The development and use of Clinical Indicators is 
increasing world-wide, and in Australia there are other 
organisations, including the Australian Commission on 
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Introduction
Twenty-two years ago the first set of Clinical Indicators (CIs) 
was introduced into the Australian Council on Healthcare 
Standards (ACHS) accreditation program. Initial support 
came from the Commonwealth Department of Health, 
which provided a total of approximately $2.2 million 
(in three yearly development grants) over a decade, and 
from Baxter Healthcare P/L. The co-operation of the Med-
ical Colleges enabled relevant clinician input into the CI 
development.
This paper is written for the benefit of both healthcare 
administrators and clinicians, particularly for those involved 
in quality review and what is currently termed ‘clinical 
governance’, to inform of the changes which have occurred 
since the introduction of the program with regard to its 
growth, the CI development and revision process, the 
supporting information provided for contributors, the data 
collection process, the database itself and the changes in 
clinical practice, which are reflected in the data and which, 
to some extent, may have resulted from a process which 
allows for self (over time) and peer comparison.
Twenty-one years ago data from 115 healthcare organ-
isations (HCOs) on one set containing 15 Hospital-Wide 
CIs were released. The CIs had been developed with the 
co-operation of the Royal Australian (now Australasian) 
College of Medical Administrators (RACMA). It was a world 
first for accreditation programs. Currently data are received 
from over 800 HCOs on 22 indicator sets containing over 
300 individual CIs. All major disciplines are represented and 
the national clinical database, in its diversity, is the most 
comprehensive of its type in the world. The last printed 
report of the aggregate results was in 2003. If produced in
hardcopy now it would amount to well over 600 pages. 
However the report is available annually via the internet or 
on CD and a hard copy summary of results remains avail-
able as the Australasian Clinical Indicator Report (ACIR) 
[1] (Australasian as a number of New Zealand HCOs now 
participate in the Clinical Indicator Program). Considering 
that the provision of CI data by HCOs is voluntary that is a 
significant achievement.
The ACHS now assists HCOs in data reporting through the 
provision of the Performance Indicator Reporting Tool (PIRT) 
and analysis of the data is performed externally each year 
for the ACHS by the Health Services Research Group at the 
University of Newcastle. Trending of data is only performed 
when there are four or more years of data available.
The program was introduced to measure and improve the 
quality of care, to increase clinician interest and involve-
ment in quality activities and to lessen the possibility of an 
HCO receiving full accreditation and yet having poor patient 
management and outcomes.
Clinical Indicator selection
Content validity of the indicators is assured by their being 
provider developed. Three criteria were required in the 
development of a CI, namely that the subject chosen was 
of clinical importance, that data were available for its 
assessment and that as a CI it was responsive, i.e. that it 
could induce a change in clinical practice. These criteria 
remain appropriate to use today. In more detail they are:
1.  Clinical significance
1.1  Disease burden (volume, cost, concern)
1.2  Content validity (measure of quality)
1.3  Evidence base (level of evidence)
2.  Data value
2.1  Data elements (definable, accessible)
2.2  Reliability (accurate, reproducible)
3.  Responsiveness (potential to improve care).
The CIs in this program address either the process of care 
such as a medication requirement, or the outcome of care 
such as a wound infection. The advantage of an outcome 
CI is that it is important in its own right, but disadvantages 
are that sufficient numbers are required to reduce chance 
variation, and that case-mix and illness severity may require 
determination. [2] An advantage of process measures is that 
the facility can act upon findings more quickly, however the 
value of the process selected as a CI should be evidence-
based, as all of the current CIs are. In addition to addressing 
issues considered of importance by the providers of care 
and being supported by a comprehensive literature review, 
each set is endorsed by the relevant Medical College/Society 
prior to its release in a User Manual. The basic structure of a 
CI is shown in Box 1, together with the type of supporting 
information contained in the User Manual for each area of 
clinical activity being addressed.
HCO responses
Although provision of CI data is voluntary, HCOs are expect-
ed to provide data concerning their main service areas. 
Contributing HCOs receive six-monthly reports containing 
their results for the period, together with aggregate and 
peer comparative data. In 2014 the average number of 
individual CIs reported by HCOs was 22.
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In the early years of the program the ACHS received 
quantitative and qualitative data, the latter allowing it to 
determine the HCOs’ responses to receiving aggregate and, 
in particular, peer comparative data. Responses could be 
classified into five groups:
•  review of data accuracy e.g. a further internal audit
•  policy and procedure changes e.g. a change in antibiotic  
 prophylaxis
•  education programs e.g. on thromboembolism   
 prophylaxis
•  new appointments e.g. a discharge planning officer
•  equipment changes e.g. new type of catheter etc. [3]
Surveys of HCOs in 2014 and 2015 revealed that the above 
five types of response are still occurring.
Changes in clinical practice
Trends can be demonstrated in the ACHS national clinical 
database showing that HCOs appear to be responding to a 
review of their results and are improving the care provided. 
Of 197 CIs available for trending in the 2014 data, over 50% 
showed a trend in a desirable direction and in five of the 
indicator sets more than two-thirds of all their trended CIs 
showed improvement. [1] Analysis of 2015 data had not 
been completed at the time of submission of this paper.
CIs certainly reflect changes in patient management, for 
example with a CI requiring patients admitted with an acute 
myocardial infarct (now termed acute coronary syndrome),
to receive thrombolysis within one hour, the compliance 
rate rose from 70% on its introduction to a maximum of 
approximately 80% in 2008, but steadily fell from that year 
to approximately 60% in 2014, due to the development of 
early percutaneous coronary intervention (PCI). This CI will 
remain for HCOs without PCI facilities and those with them 
will address the ‘door to balloon time’.
However, that the introduction of a CI has affected change 
and not simply reflected it, is suggested with the CI 
addressing the compliance rate in the provision of antibiotic
prophylaxis for caesarean section. This was below 60% in 
2008, when the CI was introduced, and rose to over 90% by 
2012, a level that has been maintained since. This early ‘slope 
of improvement’ can be demonstrated with many of the CIs.
Some other examples of statistically significant improvement 
over time in patient care are shown in Table 1, which lists 
the aggregate rates reported in 2007 and 2014 for seven 
CIs, which, having not been revised over that period, can 
be compared. The 2014 denominators for these seven CIs 
varied from approximately 11,000 patients (from 20 HCOs) 
for the Hospital in the Home CI to over 445,000 patients 
(from 144 HCOs) for the Emergency Medicine CI.
Cost-avoidance can also be shown, for example with the 
generic CI ‘Unplanned Readmission’. The rate in 1998 was 
approximately 2.2% and in 2014 it was 1.17%. The cost 
avoidance (through the decreased rate) for the year 2014 
would amount to over $200 million. Whilst fewer HCOs 
reported data in 2014 than in 1998, there was a 40% increase 
in the number of patients in the denominator (over 3.25 
million) for 2014. In addition to improvements in medical 
and nursing practice, which would have occurred over that 
time, it is also likely that the introduction of the unplanned 
re-admissions CI had some influence through the action 
taken by HCOs of employing nurse discharge planners.
Clinical Indicator revision
As medical care evolves and improves one constant 
challenge, from the program’s inception, was ensuring 
that the CIs remained current and that the support and 
participation of clinicians were maintained. An example 
of the need for currency is the thrombolysis vs PCI issue 
mentioned above. Much time, effort and funding have been
Box 1: An indicator in the area of cardiovascular disease and the type of information provided in the User Manual for 
Internal Medicine Clinical Indicators Version 6
Congestive Heart Failure (CHF) – prescribed beta blocker
ClINICAl INDICATOR
Numerator – Number of patients discharged with a 
diagnosis of CHF who have no contraindications to use 
of beta blockers and who are prescribed beta blocker
therapy, during the 6 month time period
Denominator – Number of patients discharged with 
a diagnosis of CHF and who have no contraindications 
to use of beta blockers, during the 6 month time period
USER MANUAl SUPPORT
• Rationale
• Reporting period
• Inclusions/exclusions
• Data cleaning rules
• Definition of terms
• Background, providing evidence base and references
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directed at periodic revision of the CI sets, such that nine 
sets are in their fifth or more version and the first set 
introduced, the Hospital-Wide CIs, is in its twelfth year. The 
revisions are now performed by relevant multidisciplinary 
working parties plus a consumer, and still require approval 
by the relevant Medical (and Nursing) College or Society 
before their adoption. Unfortunately, despite ACHS efforts, 
the Surgical set of CIs was not revised for over a decade 
[4] and the Royal Australasian College of Surgeons is now 
more supportive of national audits conducted in specific 
disciplines, such as vascular surgery. Some of the Surgical 
CIs are able to be addressed in the Hospital-Wide set, for 
management of patients undergoing complex procedures, 
such as coronary artery grafts, is essentially multidisciplinary. 
Data on 21 CIs (across three CI sets) reflecting surgical 
practice will continue to be collected.
If an external audit replaces a CI process, an accrediting 
body should be reassured when surveying an HCO that 
audit information would be:
•  current and available at the time of survey
•  inclusive of relevant providers in the HCO being surveyed
•  cover the majority of procedures performed in a   
 particular time frame
•  contain morbidity and mortality data relevant to the HCO
•  enable comparative data review with peer HCOs.
In its inaugural year of 2010 the Australasian Vascular 
Surgical Audit captured 65% of procedures performed. [5] 
For elective open repair of an abdominal aortic aneurysm 
there were 573 procedures reported with an in-hospital 
mortality of 2.4%. The ACHS data reported 696 procedures 
in the same year with a mortality rate below 2%. [4] It had 
been just over 3% for the previous decade and it is likely that 
the fall was due to the inclusion in the ACHS data of some 
percutaneous repairs, as the requirement that only ‘open’ 
repairs are reported has just recently been included in the 
ACHS CI. This is another example of the constant need for 
CI revision.
Data accuracy
Accuracy of the ACHS CI data has been addressed previously. 
[6] Occasionally a published study provides an opportunity 
for comparison of results, as with a recent report on 
mortality related to after-hours discharge from an intensive 
care unit, which is also an ACHS CI, using the Australian and 
New Zealand Intensive Care Society (ANZICS) Adult Patient
Database (APD). [7] The mortality rates obtained in each 
database differed only slightly, being 15.4% for the years 
2005-2012 in the ANZICS APD and 15.9% for the years 2007-
2013 in the ACHS database. The ACHS had no comparative 
data for the period 2005-2006 as the CI was only introduced 
in 2007, so the time periods could not be exactly matched.
It is important to recognise that the ACHS CI program is one 
of review and not research.
When a review program flags a problem and the cause 
is evident a recommendation can be made and a further 
review subsequently conducted. If the cause is not evident 
then a research project can be mounted, with the extra 
Table 1. Comparison of Selected CI data from 2007 and 2014
 INDICATOR SET   ClINICAl INDICATOR  2007 RATE  2014 RATE*
 Emergency Medicine  ATS Category 2 patients attended  74.7  80.5 
  within 10 minutes
 Gynaecology Unplanned blood tranfuion with gynaecological 1.3% 80.5%
  surgery for benign disease
 Hospital-Wide Significant adverse blood transfusion events 0.27% 0.18%
 Hospital in the Home   Patients having 1 unscheduled staff callout 1.38% 0.54%
 (HITH)
 ICU Adult patients transferred to another facility 1.28% 0.77%
  due to bed unavailability
 Infection Control Combined superficial and deep infection following 0.89% 0.47%
  hip prosthesis procedures
 Mental Health Inpatient Inpatient discharged on > 3 pychotropic 9.79% 4.1%
  medications
*All 2014 rates shown differ significantly from those for 2007
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resources required in terms of personnel, time and funds to 
obtain data on every possible event, with the expectation of 
then determining a cause.
Outliers
Participating HCOs receive reports identifying areas where 
their rates differ significantly from the overall rate, i.e. where 
they are outliers. In 2014, as in previous years, such outliers
occurred in all sets, with only around 25% of HCOs having 
none and 50% having both desirable and undesirable 
outliers. Those HCOs that report on fewer CIs have fewer 
outliers.
Thus the CI data aught not be used for ‘League Tables’, but 
are best used for internal reviews, which HCOs are expected 
to undertake.
Programs in other countries
Clinical Indicator programs have been established in North 
America, the United Kingdom, Europe and Asia. The list of 
individual countries with such programs continues to grow,
confirming the value placed on CIs by healthcare 
bureaucracies world-wide. In the United States the Joint 
Commission introduced CIs into its accreditation program 
in 1999, having first outlined the concept in its 1987 policy 
‘Agenda for Change’. As with the ACHS there has been 
constant revision of its CIs. Currently there are 14 sets of core 
measures from which North American HCOs are expected 
to choose the measures they will address, and their 
reported data may be made public. [8] Other early and quite 
comprehensive programs were developed in Scotland, in 
1993 [9] and Denmark in 2000. [10]
Other Australian programs
A further challenge for the ACHS is that its CI program 
remains a requisite for ensuring a high quality of patient 
care, as clinical performance measures are developed 
by various other Australian healthcare authorities. The 
Australian Commission on Safety and Quality in Healthcare 
has recently produced a set of hospital-based outcome 
indicators addressing inhospital mortality, re-admissions 
and hospital acquired infection. [11]
Whilst much information for these indicators can be 
obtained from administrative databases, they are limited in 
relation to knowledge of illness severity and preventability. 
For example a re-admission to hospital might be recognised 
as unplanned, but not that it was unexpected. This is an 
important advantage of the ACHS national clinical database, 
for not all of the apparently failed processes of care or 
untoward outcomes will be avoidable.
Have the ACHS CI program’s aims been met?
As stated above, improvement in the quality of care can 
be demonstrated in the high number of desirable trends 
evident in the ACHS CI database. Indicators, such as the 
requirement to conduct a clinical review of obstetric adverse 
events, which has risen from approximately 50% of cases in 
2009 having a review to 100% in 2014, along with the limited
amount of qualitative data the ACHS receives, suggest that 
there is strong clinician interest in quality activities. A recent 
online questionnaire and phone interviews concerning 
the use of Day Patient CIs also confirmed that CI data are 
presented regularly to senior clinical and administrative staff 
and acted upon to improve patient management. [12]
Although there is no incontrovertible evidence to indicate 
that the likelihood of an HCO with inadequate patient 
management processes and outcomes being accredited 
has been lessened, significant advances in accreditation 
survey processes, including the requirement for HCOs 
to demonstrate evidence of improvement in patient 
management and outcomes, has significantly reduced such 
a likelihood.
The extensive coverage of clinical activities reflected in 
the ACHS CI sets, and the important provider input in their 
development and revision, should ensure their continued 
use and influence in assessing standards of care in Australian 
HCOs and, most importantly, in providing a stimulus to 
improvement in that care. Brand et al reporting on a survey 
of Australian public hospitals conducted in 2005, found 
that 99% of the hospitals surveyed measured clinical 
performance, with 72% using CIs to do so. [13] Presumably 
the majority of the CIs used at that time were from the ACHS 
program. However, only a brief reference to one ACHS CI 
was made in a Medical Journal of Australia supplement in 
2010 devoted to the gathering of clinical information to 
improve care. [14] There is clearly a challenge for the ACHS 
in the promotion of its unique national clinical database. It 
is now developing as an international database, with the 
recent participation of Hong Kong, Indonesia and Saudi 
Arabia in addition to New Zealand, although the number 
of HCOs participating from those countries remains small at 
this stage.
Given the amount of data and information available to HCOs 
today, the ACHS aims to ensure its data are easily interpreted, 
supported by healthcare personnel experienced in quality 
assessment and most importantly, are used by HCOs as a 
critical element to improve patient outcomes. As the great 
Dr W Edwards Deming wrote ‘There is no substitute for 
knowledge’. [15]
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